Fig. 4From: Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasisKaplan–Meier plot of progression-free survival and of overall survival in the patients with brain metastases (A) and (B), respectively, in the patients with bone metastases (C) and (D), respectively, and in the patients with liver metastases (E) and (F), respectivelyBack to article page